KLOW
A four-compound regenerative research blend — the GLOW formulation with KPV added for inflammatory-signaling work.
01At a Glance
| Compound | KLOW |
| Classification | Regenerative research compound |
| Constituents | BPC-157 10 mg — 1,419.5 g/mol GHK-Cu 50 mg — 404.92 g/mol TB-500 10 mg — 4,963.4 g/mol KPV 10 mg — 410.51 g/mol |
| Molecular weight | Blend — see constituents |
| Sequence / Form | BPC-157 10 mg · GHK-Cu 50 mg · TB-500 10 mg · KPV 10 mg |
| Purity | ≥98% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
02Mechanism of Action
KLOW is the GLOW blend with the addition of KPV, the C-terminal tripeptide of α-MSH. Where GLOW’s three constituents are studied in repair and matrix signaling, KPV research centres on NF-κB inhibition and pro-inflammatory cytokine expression.
The stated rationale for the four-compound form is to place repair-pathway and inflammatory-pathway compounds in one preparation for combined in-vitro work. KPV’s reported activity appears largely independent of melanocortin receptors, pointing to an intracellular mechanism.
As with GLOW, no published literature characterises the combination itself. Research framing rests on the individual constituent literature.
Research framing only · No human-use claims
03Research Context
- Combined repair and inflammatory-pathway assays
- NF-κB signaling with concurrent matrix remodeling
- Cytokine-expression models
- Multi-compound in-vitro preparation studies
04Quality & Verification
Ethos Bio presents compound information with an emphasis on identity verification, purity analysis, certificate access, and storage guidance. Product-specific documentation is available through the certificate page where applicable. Cold-chain shipping is available where required, and inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
05FAQ
What is in KLOW?
KLOW is a single lyophilized vial containing BPC-157 10 mg, GHK-Cu 50 mg, TB-500 10 mg and KPV 10 mg — 80 mg total peptide content.
How does KLOW differ from GLOW?
KLOW is the same three-compound GLOW base with KPV 10 mg added. KPV is studied for NF-κB and inflammatory-signaling modulation, which the other three are not.
Is there research on the KLOW combination itself?
No. Published research covers the four constituents individually. Ethos Bio makes no claims about the combination.
How should KLOW be stored?
KLOW ships lyophilized and should be handled per standard research-peptide practice — kept cold, protected from light and moisture, and reconstituted only for laboratory use. Cold-chain handling is used where required. For research use only.
Is KLOW approved for human use?
No. KLOW is sold strictly for laboratory research use only and is not a drug or supplement. It is not approved for human or veterinary use or consumption.
How is KLOW tested at Ethos Bio?
Every lot is independently verified by Kovera Labs on a third-party analytical panel — RP-HPLC purity and HPLC-MS identity confirmation — and a lot-specific certificate of analysis issued to Ethos Bio ships with the vial. See How We Test for the full methodology.